Robin Jones to Platelet-Derived Growth Factor
This is a "connection" page, showing publications Robin Jones has written about Platelet-Derived Growth Factor.
Connection Strength
0.183
-
Circulating Tumor Cells and Biomarker Modulation with Olaratumab Monotherapy Followed by Olaratumab plus Doxorubicin: Phase Ib Study in Patients with Soft-Tissue Sarcoma. Mol Cancer Ther. 2021 01; 20(1):132-141.
Score: 0.183